The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 30, 2009

Filed:

Mar. 06, 2007
Applicants:

Gad S. Cojocaru, Ramat-HaSharon, IL;

Sarah Pollock, Tel-Aviv, IL;

Zurit Levine, Herzlia, IL;

Alexander Diber, Rishon-LeZion, IL;

Guy Kol, Givat Shmuel, IL;

Amir Toporik, Azur, IL;

Rotem Sorek, Rechovot, IL;

Dvir Dahary, Tel-Aviv, IL;

Michal Ayalon-soffer, Ramat-HaSharon, IL;

Pinchas Akiva, Ramat-Gan, IL;

Amit Novik, Beit-HaSharon, IL;

Yossi Cohen, Banstead, GB;

Osnat Sella-tavor, Kfar Kish, IL;

Shira Walach, Hod-HaSahron, IL;

Shirley Sameah-greenwald, Kfar Saba, IL;

Ronen Shemesh, Modlin, IL;

Maxim Shklar, Tel-Aviv, IL;

Inventors:

Gad S. Cojocaru, Ramat-HaSharon, IL;

Sarah Pollock, Tel-Aviv, IL;

Zurit Levine, Herzlia, IL;

Alexander Diber, Rishon-LeZion, IL;

Guy Kol, Givat Shmuel, IL;

Amir Toporik, Azur, IL;

Rotem Sorek, Rechovot, IL;

Dvir Dahary, Tel-Aviv, IL;

Michal Ayalon-Soffer, Ramat-HaSharon, IL;

Pinchas Akiva, Ramat-Gan, IL;

Amit Novik, Beit-HaSharon, IL;

Yossi Cohen, Banstead, GB;

Osnat Sella-Tavor, Kfar Kish, IL;

Shira Walach, Hod-HaSahron, IL;

Shirley Sameah-Greenwald, Kfar Saba, IL;

Ronen Shemesh, Modlin, IL;

Maxim Shklar, Tel-Aviv, IL;

Assignee:

Compugen Ltd, Tel Aviv, IL;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/02 (2006.01); C07H 21/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

Novel markers for ovarian cancer that are both sensitive and accurate. These markers are overexpressed and/or differentially expressed in ovarian cancer specifically, as opposed to normal ovarian tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis, in ovarian cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between ovarian cancer and non-cancerous states.


Find Patent Forward Citations

Loading…